Significados de personalize treatment en inglés

Both approaches require personalized treatment strategies based on patient genotypes.

Identification of potential novel imaging biomarkers will allow a personalized treatment plan for every patient.

We can use these HCC classification criteria to stratify patients into subtypes for personalized treatment.

Non-invasive blood-based monitoring of these mutations may pave the way to a fine-tuned personalized treatment.

In the future, a personalized treatment approach will probably achieve a better control of disease manifestations.

Tumor heterogeneity greatly limits personalized treatment of cancer.

It is apparent that personalized treatment management will be required in this new era of targeted treatment.

Therefore, more efficient prognostic biomarkers are needed for improved risk stratification, personalized treatment, and prognostication of RC patients.

Biomarkers are used to assist clinicians with timely diagnosis, prognosis, and risk prediction of patients for personalized treatment.

Genetic interaction (GI) detection impacts the understanding of human disease and the ability to design personalized treatment.

Intratumoral heterogeneity poses a major challenge to making an accurate diagnosis and establishing personalized treatment strategies for cancer patients.

It will enhance the worldwide implementation of MRI and consequently improve personalized treatment of patients with suspected pancreatic ductal adenocarcinoma.

And if utility is proven, personalized treatment regimes, duration of treatment, and threshold values for vitamin D should be provided.

Findings can inform practitioners interested in the impact of childhood adversity and personalizing treatment approaches of obesity within high-risk populations.

This is a step in the direction of personalized treatment for gastrointestinal disorders based on optimized subtyping of anorectal disorders.

Recently, MET was suggested to be a potential target for the personalized treatment of HCC with an active HGF-MET signaling pathway.